Evidence map›Paper›PMID 35250577›Full record

ArticleFrontiers in pharmacology2022

Accessibility of Essential Medicines for Children in Sichuan Province of China: A Cross-Sectional Study.

Zhe Chen, Siyu Li, Imti Choonara, Linan Zeng, Zhi-Jun Jia, Guo Cheng, Qin Yu, Lingli Zhang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Access to medicines for children in China.BMJ paediatrics open · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Zhe ChenWest China School of Pharmacy, Sichuan University, Chengdu, China.
Siyu LiDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Imti ChoonaraAcademic Division of Child Health, Derbyshire Children's Hospital, University of Nottingham, Derby, United Kingdom.
Linan ZengDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Zhi-Jun JiaWest China School of Pharmacy, Sichuan University, Chengdu, China.
Guo ChengKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China.
Qin YuKey Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Chengdu, China.
Lingli ZhangDepartment of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Ministry of Education of the People's Republic of China · CNSichuan University · CNDerbyshire Children's Hospital · GBWest China Second University Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

accessibilityaffordabilityavailabilitychildrencross-sectional studymedicineprice

Identifiers

PMID35250577
PMCPMC8888852
OpenAlexW4212836731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.